INCLISIRAN for Hypercholesterolaemia: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 486 adverse event reports in the FDA FAERS database where INCLISIRAN was used for Hypercholesterolaemia.
Most Reported Side Effects for INCLISIRAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Arthralgia | 689 | 10.8% | 2 | 23 |
| Myalgia | 518 | 8.1% | 0 | 14 |
| Injection site pain | 488 | 7.7% | 0 | 20 |
| Low density lipoprotein increased | 423 | 6.7% | 3 | 5 |
| Pain in extremity | 417 | 6.6% | 0 | 34 |
| Pain | 342 | 5.4% | 1 | 27 |
| Fatigue | 325 | 5.1% | 3 | 26 |
| Drug ineffective | 318 | 5.0% | 1 | 17 |
| Diarrhoea | 309 | 4.9% | 1 | 29 |
| Dyspnoea | 297 | 4.7% | 10 | 52 |
| Headache | 234 | 3.7% | 2 | 19 |
| Rash | 207 | 3.3% | 0 | 10 |
| Product storage error | 204 | 3.2% | 0 | 0 |
| Muscle spasms | 202 | 3.2% | 0 | 16 |
| Injection site reaction | 179 | 2.8% | 0 | 2 |
Other Indications for INCLISIRAN
Product used for unknown indication (3,669)
Arteriosclerosis (539)
Hyperlipidaemia (516)
Low density lipoprotein increased (392)
Type iia hyperlipidaemia (313)
Blood cholesterol increased (161)
Low density lipoprotein decreased (106)
Low density lipoprotein (103)
Dyslipidaemia (94)
Coronary artery disease (60)
Other Drugs Used for Hypercholesterolaemia
EVOLOCUMAB (23,505)
ATORVASTATIN (5,615)
ALIROCUMAB (4,924)
SIMVASTATIN (3,010)
ROSUVASTATIN (2,690)
EZETIMIBE (1,589)
PRAVASTATIN (764)
FENOFIBRATE (286)
FLUVASTATIN (264)
BEMPEDOIC ACID (228)